Abstract
Progression of many cancers is associated with tumor infiltration by mesenchymal stromal cells (MSC). Adipose stromal cells (ASC) are MSC that serve as adipocyte progenitors and endothelium-supporting cells in white adipose tissue (WAT). Clinical and animal model studies indicate that ASC mobilized from WAT are recruited by tumors. Direct evidence for ASC function in tumor microenvironment has been lacking due to unavailability of approaches to specifically inactivate these cells. Here, we investigate the effects of a proteolysis-resistant targeted hunter-killer peptide D-WAT composed of a cyclic domain CSWKYWFGEC homing to ASC and of a proapoptotic domain KLAKLAK2. Using mouse bone marrow transplantation models, we show that D-WAT treatment specifically depletes tumor stromal and perivascular cells without directly killing malignant cells or tumor-infiltrating leukocytes. In several mouse carcinoma models, targeted ASC cytoablation reduced tumor vascularity and cell proliferation resulting in hemorrhaging, necrosis, and suppressed tumor growth. We also validated a D-WAT derivative with a proapoptotic domain KFAKFAK2 that was found to have an improved cytoablative activity. Our results for the first time demonstrate that ASC, r...Continue Reading
References
May 11, 2004·Nature Medicine·Mikhail G KoloninWadih Arap
Nov 19, 2004·Nature·Neil A BhowmickHarold L Moses
Oct 5, 2007·Nature·Antoine E KarnoubRobert A Weinberg
Oct 31, 2007·Circulation Research·Dmitry O TraktuevKeith L March
Mar 25, 2009·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Christophe F ChantrainYves A DeClerck
Jun 6, 2009·Cancer Research·Yan ZhangMikhail G Kolonin
Nov 30, 2010·Reproductive Biology·Emily C CalleryPaweł M Bartlewski
Jun 21, 2011·Cell Stem Cell·Alexes C DaquinagMikhail G Kolonin
Dec 15, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ann H KloppMikhail G Kolonin
Jan 3, 2012·Stem Cell Research·Mikhail G KoloninRichard H Gomer
Mar 24, 2012·Cancer Cell·Douglas Hanahan, Lisa M Coussens
May 26, 2012·Drug Discovery Today·Olga Sirin, Mikhail G Kolonin
Oct 17, 2012·Cancer Research·Yan ZhangMikhail G Kolonin
Feb 26, 2013·Nature Cell Biology·Ryan Berry, Matthew S Rodeheffer
May 9, 2013·Nature Communications·Younghun JungRussell S Taichman
Aug 7, 2013·Cancer Research·Stefania OrecchioniFrancesco Bertolini
Mar 4, 2014·PloS One·Brian G RowanErnest S Chiu
Apr 10, 2014·The American Journal of Pathology·Rebeca San MartinDavid R Rowley
Jun 18, 2014·Nature Reviews. Endocrinology·Jiyoung ParkPhilipp E Scherer
Oct 25, 2014·Cell Death and Differentiation·A C DaquinagM G Kolonin
Citations
Oct 11, 2016·Molecular Therapy. Methods & Clinical Development·Giuseppe RonzittiFederico Mingozzi
Feb 1, 2017·Current Rheumatology Reports·Ilja L Kruglikov
Nov 22, 2018·Nature Reviews. Endocrinology·Daniela F Quail, Andrew J Dannenberg
Oct 27, 2018·Oncogene·Fei SuMikhail G Kolonin
Jul 11, 2020·The Biochemical Journal·Yasuhiro OnogiSiegfried Ussar
Nov 22, 2017·Development·Zhanguo GaoMikhail G Kolonin
Dec 6, 2017·The Pharmacogenomics Journal·D I StaquiciniR Pasqualini
Apr 8, 2020·Cells·Kristin Eckel-MahanMikhail G Kolonin
Nov 27, 2019·International Journal of Molecular Sciences·Gaetano AurilioRodolfo Montironi
Jul 9, 2017·Cancer Research·Achinto SahaJohn DiGiovanni
Dec 16, 2020·Cells·Alexes C DaquinagMikhail G Kolonin
Mar 24, 2021·NPJ Precision Oncology·Fei SuMikhail G Kolonin
Jun 11, 2021·Nature Communications·Aleix Ribas-LatreKristin L Eckel-Mahan
Oct 6, 2021·Cancer Research·Shraddha SubramanianMikhail G Kolonin